SBFM SUNSHINE BIOPHARMA INC Capital Structure Changes 8-K Filing 2024 - Exception Granted by Nasdaq Sunshine Biopharma, Inc. received an exception from Nasdaq to regain compliance with minimum bid price requirement.Get access to all SEC 8-K filings of the SUNSHINE BIOPHARMA INC